Sun Pharmaceutical Industries has received an Establishment Inspection Report (EIR) from the US Food Drug and Administration (USFDA) in respect of Dadra facility based upon the company’s responses to the observation letter.

EIR is issued to the entity when the USFDA concludes that an inspection is closed under Title 21 Section 20.64 (d) (3) of Code of Federal Regulation.

Total volume of shares traded on the bourses today was lower by 42.34% to 3,573,833 compared with 22-day average volume of 6,197,935.

Shares of the company gained Rs 9.55, or 1.82%, to trade at Rs 535.35. The total volume of shares traded was 193,487 at the BSE (10.07 a.m., Thursday).